Panacea Biotec plans $28 million share buyback
This article was originally published in Scrip
Executive Summary
Panacea Biotec, a leading Indian vaccine producer, plans to buy back up to 5.59 million of its own shares for up to Rs1.28 billion ($27.5 million).